STOCKHOLM, Sweden--(BUSINESS WIRE)--In accordance with Biovitrum's 2001/2006 warrant program, 66,200 shares have been issued at SEK 59 per share, with net proceeds of SEK 3,905,800. All outstanding warrants of the 2001/2006 program that expired on November 30, 2006, have now been exercised.
